Lilly’s Baricitinib Yields High Rates of Hair Regrowth in Adolescents with AA: A Q & A With Brittany Craiglow, MD
Adolescents with severe alopecia areata (AA) treated with once-daily, oral baricitinib (Olumiant, Lilly) 2mg and 4mg in the Phase 3 BRAVE-AA-PEDS study saw high rates of hair regrowth at Week 36, according to new research presented at the 2025 meeting of the American Academy of Dermatology in Orlando, FL. These data show 42.4% of patients […]